Mutations associated with neutropenia in dogs and humans disrupt intracellular transport of neutrophil elastase
- PMID: 12897784
- DOI: 10.1038/ng1224
Mutations associated with neutropenia in dogs and humans disrupt intracellular transport of neutrophil elastase
Abstract
Cyclic hematopoiesis is a stem cell disease in which the number of neutrophils and other blood cells oscillates in weekly phases. Autosomal dominant mutations of ELA2, encoding the protease neutrophil elastase, found in lysosome-like granules, cause cyclic hematopoiesis and most cases of the pre-leukemic disorder severe congenital neutropenia (SCN; ref. 3) in humans. Over 20 different mutations of neutrophil elastase have been identified, but their consequences are elusive, because they confer no consistent effects on enzymatic activity. The similar autosomal recessive disease of dogs, canine cyclic hematopoiesis, is not caused by mutations in ELA2 (data not shown). Here we show that homozygous mutation of the gene encoding the dog adaptor protein complex 3 (AP3) beta-subunit, directing trans-Golgi export of transmembrane cargo proteins to lysosomes, causes canine cyclic hematopoiesis. C-terminal processing of neutrophil elastase exposes an AP3 interaction signal responsible for redirecting neutrophil elastase trafficking from membranes to granules. Disruption of either neutrophil elastase or AP3 perturbs the intracellular trafficking of neutrophil elastase. Most mutations in ELA2 that cause human cyclic hematopoiesis prevent membrane localization of neutrophil elastase, whereas most mutations in ELA2 that cause SCN lead to exclusive membrane localization.
Similar articles
-
Hereditary neutropenia: dogs explain human neutrophil elastase mutations.Trends Mol Med. 2004 Apr;10(4):163-70. doi: 10.1016/j.molmed.2004.02.002. Trends Mol Med. 2004. PMID: 15059607 Review.
-
Neutrophil elastase-processing defect in cyclic hematopoietic dogs.Exp Hematol. 2010 Feb;38(2):104-15. doi: 10.1016/j.exphem.2009.09.010. Epub 2009 Nov 24. Exp Hematol. 2010. PMID: 19941936
-
Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis.Nat Genet. 1999 Dec;23(4):433-6. doi: 10.1038/70544. Nat Genet. 1999. PMID: 10581030
-
Severe congenital neutropenia and the unfolded protein response.Curr Opin Hematol. 2008 Jan;15(1):1-7. doi: 10.1097/MOH.0b013e3282f13cd2. Curr Opin Hematol. 2008. PMID: 18043239 Review.
-
Double de novo mutations of ELA2 in cyclic and severe congenital neutropenia.Hum Mutat. 2007 Sep;28(9):874-81. doi: 10.1002/humu.20529. Hum Mutat. 2007. PMID: 17436313
Cited by
-
Neutrophil Elastase Defects in Congenital Neutropenia.Front Immunol. 2021 Apr 22;12:653932. doi: 10.3389/fimmu.2021.653932. eCollection 2021. Front Immunol. 2021. PMID: 33968054 Free PMC article. Review.
-
α1Proteinase inhibitor regulates CD4+ lymphocyte levels and is rate limiting in HIV-1 disease.PLoS One. 2012;7(2):e31383. doi: 10.1371/journal.pone.0031383. Epub 2012 Feb 17. PLoS One. 2012. PMID: 22363634 Free PMC article.
-
Animal models of human granulocyte diseases.Hematol Oncol Clin North Am. 2013 Feb;27(1):129-48, ix. doi: 10.1016/j.hoc.2012.10.005. Epub 2012 Oct 31. Hematol Oncol Clin North Am. 2013. PMID: 23351993 Free PMC article. Review.
-
The genetic and molecular bases of monogenic disorders affecting proteolytic systems.J Med Genet. 2005 Jul;42(7):529-39. doi: 10.1136/jmg.2004.028118. J Med Genet. 2005. PMID: 15994873 Free PMC article. Review.
-
Neutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.Pharmacol Rev. 2010 Dec;62(4):726-59. doi: 10.1124/pr.110.002733. Pharmacol Rev. 2010. PMID: 21079042 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases